Patent application number | Description | Published |
20080242571 | Oil Containing Starch Granules For Delivering Benefit-Additives to a Substrate - An oil containing starch granule is provided comprising:
| 10-02-2008 |
20080242578 | Oil Containing Starch Granules For Delivering Benefit-Additives to a Substrate - An oil containing starch granule is provided comprising: | 10-02-2008 |
20090202466 | Oligomeric Amidoamides or Amidoquats for Fabric or Hair Treatment Compositions - Provided are oligomeric amidoamines, an oligomeric amidoamine salt of the oligomeric amidoamine, and/or an oligomeric amidoquat of the oligomeric amidoamine. These materials can be used as fabric softeners in fabric softener compositions or as a hair treatment in hair treatment compositions. | 08-13-2009 |
20120035092 | LIQUID CLEANING COMPOSITIONS WITH FILMS - A cleaning composition that contains film flakes with beneficial ingredients. The composition with the film flakes releases the beneficial ingredients when it is delivered to the target surface. | 02-09-2012 |
20140023598 | FUNCTIONAL FRAGRANCE PRECURSOR - The present invention relates to a class of fragrance precursor compounds comprising one or more of the compounds derived from the reaction of X—OH and an aldehyde or ketone, said fragrance precursor compounds being of the formula X—O—C(R)(R*)(OR**) wherein R is a C | 01-23-2014 |
20140056825 | FUNCTIONAL FRAGRANCE PRECURSOR - The present invention relates to a class of fragrance precursor compounds comprising one or more of the compounds derived from the reaction of X—OH and an aldehyde or ketone, said fragrance precursor compounds being of the formula X—O—C(R)(R*)(OR**) wherein R is a C | 02-27-2014 |
20140056826 | FUNCTIONAL FRAGRANCE PRECURSOR - The present invention relates to a class of fragrance precursor compounds comprising one or more of the compounds derived from the reaction of X—OH and an aldehyde or ketone, said fragrance precursor compounds being, of the formula X—O—C(R)(R*)(OR**) wherein R is a C | 02-27-2014 |
20140065081 | FUNCTIONAL FRAGRANCE PRECURSOR - The present invention relates to a class of fragrance precursor compounds comprising one or more of the compounds derived from the reaction of X—OH and an aldehyde or ketone, said fragrance precursor compounds being of the formula X—O—C(R)(R*)(OR**) wherein R is a C | 03-06-2014 |
Patent application number | Description | Published |
20110184761 | Method and Apparatus for Estimating Patient Populations - The methods and apparatuses of the present invention provide for a continuous abstraction of randomly sampled patient data and shortened data processing cycle times when an accurate sample population size is unknown at the beginning of the sampling process. The present invention estimates an initial medical patient population size for the purpose of randomly sampling that population. The estimated population size is calculated based on historical patient population data and is corrected at the end of the sample time period. Under-sampling is remediated at the end of the sample time period, during which continuous sampling of the patient data is carried out to provide interim and immediately available sampled patient data. Criteria for medical patient population sizing and sampling are provided by health care organizations responsible for administrating health care quality improvement standards. | 07-28-2011 |
20110202486 | Healthcare Information Technology System for Predicting Development of Cardiovascular Conditions - Described herein is a framework for predicting development of a cardiovascular condition of interest in a patient. The framework involves determining, based on prior domain knowledge relating to the cardiovascular condition of interest, a risk score as a function of patient data. The patient data may include both genetic data and non-genetic data. In one implementation, the risk score is used to categorize the patient into at least one of multiple risk categories, the multiple risk categories being associated with different strategies to prevent the onset of the cardiovascular condition. The results generated by the framework may be presented to a physician to facilitate interpretation, risk assessment and/or clinical decision support. | 08-18-2011 |
20110295621 | Healthcare Information Technology System for Predicting and Preventing Adverse Events - An adverse event may be prevented by predicting the probability of a given patient to have or undergo the adverse event. The probability alone may prevent the adverse event by educating the patient or medical professional. The probability may be predicted at any time, such as upon entry of information for the patient, periodic analysis, or at the time of admission. The probability may be used to generate a workflow action item to reduce the probability, to warn, to output appropriate instructions, and/or assist in avoiding adverse event. The probability may be specific to a hospital, physician group, or other medical entity, allowing prevention to focus on past adverse event causes for the given entity. | 12-01-2011 |
20110295622 | Healthcare Information Technology System for Predicting or Preventing Readmissions - Hospital readmissions may be prevented. Readmission is prevented by predicting the probability of a given patient to be readmitted. The probability alone may prevent readmission by educating the patient or medical professional. The probability may be predicted during a patient stay and used to generate a workflow action item to reduce the probability, to warn, to output appropriate instructions, and/or assist in avoiding readmission. The probability may be specific to a hospital, physician group, or other entity, allowing prevention to focus on past readmission causes for the given entity. | 12-01-2011 |
20120041784 | Computerized Surveillance of Medical Treatment - Medical treatment is automatically surveyed. Drugs or other treatments may be monitored post-market. This surveillance may be accomplished in two ways: (1) Identify patients that potentially match templates consistent with possible adverse reactions, possibly including adverse reactions not associated with the treatment. Potentially, if the match is good enough, a single patient may be sufficient to raise an alert. Alternately, multiple patients partially matching a template may cause an alert. (2) Identify patient clusters with unusual patterns. Multiple patients associated with greater rates of adverse events or event severity not expected with the treatment are identified. The data for surveillance is acquired from multiple sources, so may be more comprehensive for early recognition of adverse effects. Data gathering and surveillance are computerized, so early, cost effective recognition may be more likely. | 02-16-2012 |
20120065987 | Computer-Based Patient Management for Healthcare - Computer-based patient management is provided for healthcare. Patient data is used to determine a severity, assign a patient to a corresponding diagnosis-related group, and provide a timeline for care at a medical facility. Reminders or alerts are sent to maintain the timeline for more cost effective care. Reminders, suggestions, transitions between care givers, scheduling and other risk management actions are performed. As more data becomes available as part of the care, the care and timeline may be adjusted automatically for more efficient utilization of resources. Accountable care optimization is provided as part of case management. Automated care before any injury or illness and automated care after discharge is provided to optimize the health and costs for a patient. The patient is assigned to the cohort based on the patient data. | 03-15-2012 |
20120065997 | Automatic Processing of Handwritten Physician Orders - Physician orders are automatically processed. Rather than requiring entry with a user interface in a computerized order entry system, physician orders may be handwritten on a piece of paper or entered on another handwriting device. The orders are scanned or transmitted. Using a lexicon limited to the vocabulary of possible orders, handwriting recognition is applied to the scanned order. By limiting the lexicon, the accuracy of the optical character recognition may be increased. The lexicon may be further limited by determining a diagnosis and/or treatment or imaging modality for the patient and selecting a lexicon limited to orders associated with the diagnosis or modality. The recognized order is then implemented by the computerized order entry system. | 03-15-2012 |
20130046558 | System and Method for Identifying Inconsistent and/or Duplicate Data in Health Records - A method of identifying information in electronic medical records includes receiving one or more electronic medical records extracted from at least one source. Each of the one or more electronic medical records has medical information of at least one medical patient. The method also includes analyzing, via a processor, the medical information by comparing different portions of data in the medical information. The method further includes identifying, via the processor, at least one of: (i) the different portions of data in the medical information as inconsistent data; and (ii) the different portions of the data in the medical information as duplicate data. | 02-21-2013 |
20140088989 | Rapid Learning Community for Predictive Models of Medical Knowledge - A predictive model of medical knowledge is trained from patient data of multiple different medical centers. The predictive model is machine learnt from routine patient data from multiple medical centers. Distributed learning avoids transfer of the patient data from any of the medical centers. Each medical center trains the predictive model from the local patient data. The learned statistics, and not patient data, are transmitted to a central server. The central server reconciles the statistics and proposes new statistics to each of the local medical centers. In an iterative approach, the predictive model is developed without transfer of patient data but with statistics responsive to patient data available from multiple medical centers. To assure comfort with the process, the transmitted statistics may be in a human readable format. | 03-27-2014 |
20140095201 | Leveraging Public Health Data for Prediction and Prevention of Adverse Events - An adverse event may be prevented by predicting the probability of a given patient to have or undergo the adverse event. The ability to predict the probability of the adverse event may be enhanced when a model is derived from public health data to categorize and propose values for medical record fields. The probability alone may prevent the adverse event by educating the patient or medical professional. The probability may be predicted at any time, such as upon entry of information for the patient, periodic analysis, or at the time of admission. The probability may be used to generate a workflow action item to reduce the probability, to warn, to output appropriate instructions, and/or assist in avoiding adverse event. The probability may be specific to a hospital, physician group, or other medical entity, allowing prevention to focus on past adverse event causes for the given entity. | 04-03-2014 |
20140095203 | MEDICAL WORKFLOW DETERMINATION AND OPTIMIZATION - Workflows for medical entities are determined and evaluated by determining a plurality of medical tasks based on an analysis of a plurality of electronic medical records of a medical entity. A workflow of the medical entity is determined based on a sequence of medical tasks, the sequence determined based on the analysis of the plurality of electronic medical records, and an evaluation of the workflow is performed based on a predefined criterion. | 04-03-2014 |
20140095204 | AUTOMATED MEDICAL COHORT DETERMINATION - Inclusion of a patient in a medical category is determined by triggering an analysis of an electronic medical record of the patient in response to an input of data into the electronic medical record. Identifying characteristics that indicate inclusion in the medical category with the analysis, and determining a probability the patient belongs to the medical category based on the identified characteristics. | 04-03-2014 |
20140095205 | AUTOMATED MAPPING OF SERVICE CODES IN HEALTHCARE SYSTEMS - Automatic mapping of semantics in healthcare is provided. Data sets have different semantics (e.g., Gender designated with M and F in one system and Sex designated with 1 or 2 in another system). For semantic interoperability, the semantic links between the semantic systems of different healthcare entities are created (e.g., Gender=Sex and/or 1=F and 2=M) by a processor from statistics of the data itself. The distribution of variables, values, or variables and values, with or without other information and/or logic, is used to create a map from one semantic system to another. Similar distributions of other variable and/or values are likely to be for variables and/or values with the same meaning. | 04-03-2014 |
20140095206 | ADAPTIVE MEDICAL DOCUMENTATION SYSTEM - Adaptive medical data collection for medical entities may involve triggering an analysis of electronic records in response to information input into an Electronic Medical Record (EMR) of a patient. Determining a potential condition for the patient based on the analysis. Identifying additional information indicated as relevant to the potential condition of the patient, and generating a request for the identified additional information. | 04-03-2014 |
20140207492 | Healthcare Information Technology System for Predicting or Preventing Readmissions - Hospital readmissions may be prevented. Readmission is prevented by predicting the probability of a given patient to be readmitted. The probability alone may prevent readmission by educating the patient or medical professional. The probability may be predicted during a patient stay and used to generate a workflow action item to reduce the probability, to warn, to output appropriate instructions, and/or assist in avoiding readmission. The probability may be specific to a hospital, physician group, or other entity, allowing prevention to focus on past readmission causes for the given entity. | 07-24-2014 |
20140214451 | Adaptive Medical Documentation System - Adaptive medical data collection for medical entities may involve managing content by receiving data indicating a context, identifying at least one application or knowledge base associated with the context, designating the identified application or knowledge base as active, and accessing the active application or knowledge base to provide information at an interface point for a medical professionals and a patient. | 07-31-2014 |
20150106125 | Automated Mapping of Service Codes in Healthcare Systems - Mapping of semantics in healthcare may involve accessing first transaction data of a first healthcare entity in a first database, the first transaction data corresponding to a collection of a first number of fields defined for a condition using a first semantic system to store information and calculating a first distribution of information in the first transaction data. Mapping may also involve accessing second transaction data of a second healthcare entity in a second database, the second transaction data corresponding to a second semantic system different than the first semantic system and the second database comprising a second number of fields using the second semantic system to store information, the second number of fields larger than the first number of fields and calculating a second distribution of information in the second transaction data. The distributions may then be compared and a map relating the semantic systems may be generated. | 04-16-2015 |
20150294088 | Patient Summary Generation - Patient summary generation may involve receiving a request for summary data relating to treatment of a patient over a period of time and accessing a medical record of the patient to determine at least one condition of the patient for the period of time. Summary generation may also involve determining reporting categories relating to the at least one condition, identifying elements of the medical records associated with the reporting categories, determining data of the identified elements indicative of the summary data for the at least one condition, and compiling the summary data into a summary report. | 10-15-2015 |
20160110510 | Medical Workflow Determination And Optimization - Workflows for medical entities are determined and evaluated by determining a plurality of medical tasks based on an analysis of a plurality of electronic medical records of a medical entity. A workflow of the medical entity is determined based on a sequence of medical tasks, the sequence determined based on the analysis of the plurality of electronic medical records, and an evaluation of the workflow is performed based on a predefined criterion. | 04-21-2016 |
Patent application number | Description | Published |
20120306237 | HOOD LATCH AND STRIKER SYSTEM FOR PEDESTRIAN PROTECTION - A system for releasing and lifting an automobile hood includes a sensor located proximate a front location of an automobile that detects impact with an object. Also included is a hood having a striker pin operably connected to the hood for engaging a rotatable latch, wherein such engagement places the hood in the secured position. Further included is a releasing mechanism operably connected to one of the striker and the latch for lifting a front region of the hood in response to a signal from the sensor. | 12-06-2012 |
20130001004 | VEHICLE HOOD STRUCTURE FOR PEDESTRIAN BODY IMPACT PROTECTION - Embodiments of the present invention relate to pedestrian head impact protection. In operation, during a pedestrian impact event with a vehicle, a pedestrian protection deployable hood apparatus configured in accordance with an embodiment of the present invention causes displacement of the hood at its hinge-carrying portion for enhancing clearance an underside of the hood and a topmost surface of under-hood components. Such embodiments of the present invention contribute to providing for pedestrian head impact protection in a manner that can be implemented with a variety of hood mounting arrangements, that is effective in its results, and that is simple to package in an under-hood environment. | 01-03-2013 |
20130300134 | DEPLOYABLE HOOD LATCH FOR PEDESTRIAN HEAD PROTECTION - A motor vehicle hood latch mechanism for engaging a striker of a hood having a closed locked position and a released position is disclosed. The mechanism includes a latch assembly attached to a chassis member. The latch assembly includes a latch having a locking cam and a pawl movable between a locked position engaging the locking cam and an unlocked position away from the locking cam. A sensor detects the presence of a pedestrian proximate the front of the motor vehicle and generates a signal in response thereto. A deployment spring having an energized position and a released position is retained in an energized position by a release mechanism responsive to the signal generated by the sensor, such that actuation of the release mechanism releases the resilient member and rotates the pawl to the unlocked position to release the latch. | 11-14-2013 |
20140034407 | HOOD LATCH AND STRIKER SYSTEM FOR PEDESTRIAN PROTECTION - A system for releasing and lifting an automobile hood includes a sensor located proximate a front location of an automobile that detects impact with an object. Also included is a hood having a striker pin operably connected to the hood for engaging a rotatable latch, wherein such engagement places the hood in the secured position. Further included is a releasing mechanism operably connected to one of the striker and the latch for lifting a front region of the hood in response to a signal from the sensor. | 02-06-2014 |
20140159386 | HOOD LATCH RELEASE SYSTEM - A hood latch release system for a vehicle. The hood latch release system may have a cable and a linkage. Deflection of the cable may actuate the linkage to unlatch the hood latch. | 06-12-2014 |
20150136513 | VEHICLE FRONT END STRUCTURE PROVIDING PEDESTRIAN PROTECTION - An exemplary vehicle front end structure may include an energy absorbing structure movable between deployed and non-deployed positions. The structure may further include an actuator system that moves the energy absorbing structure from the deployed position to the non-deployed position. The energy absorbing structure in the deployed position may be spaced apart from an engine support structure by a first distance that is greater than a second distance by which the energy absorbing structure in the non-deployed structure is spaced apart from the engine support structure. | 05-21-2015 |
20150191145 | Deployable Upper Leg Stiffener for Pedestrian Protection - A pedestrian safety system for use with a motor vehicle includes a vehicle hood movable between a closed position and a raised position wherein a leading edge of the hood is raised relative to a front surface of the vehicle to form a gap, and a leg stiffener movable between a retracted position wherein it is beneath the hood when the hood is closed and a deployed position wherein the stiffener projects through the gap and is forward of the leading edge of the hood when the hood is raised. At least one actuator mounted beneath the hood moves the stiffener between the retracted and deployed positions. A remote sensing system detects an impending collision with a pedestrian and triggers the raising of the hood and extension of the actuators. | 07-09-2015 |
20150224949 | Vehicle Steering and Braking Deployment Logic for Pedestrian Protection Leg Stiffener - A method and apparatus for controlling a deployable pedestrian protection leg stiffener of a motor vehicle based upon the vehicle steering angle and/or braking status and/or speed. | 08-13-2015 |
20150283967 | Vehicle Braking Deployment Logic for Pedestrian Protection Leg Stiffener - A method and apparatus for controlling a deployable pedestrian protection leg stiffener of a motor vehicle based upon the vehicle braking status and longitudinal acceleration. | 10-08-2015 |
20150343989 | BUMPER ASSEMBLY INCLUDING AIRBAG - A bumper assembly for a vehicle includes a bumper beam and an energy absorbing member adjacent the bumper beam. An airbag module includes an inflator coupled to the bumper beam and an airbag coupled to the inflator. The airbag is disposed between the bumper beam and the energy absorbing member. The airbag is deployed during an impact between the vehicle and an object to modify the stiffness of the bumper assembly during the impact. | 12-03-2015 |
20150345185 | DEPLOYABLE HOOD RELEASE HANDLE - A motor vehicle hood latch mechanism comprises a latch assembly including a primary latch and a secondary latch. The secondary latch restrains the hood in a released position subsequent movement of the primary latch to an unlocked position. The secondary latch secures a striker to restrain the hood in a released position and allows the hood to move to an open position upon manipulation. A secondary latch release handle comprises a secondary latch release handle arm having a refracted position and a deployed position, the secondary latch release handle arm extending longitudinally forward relative the motor vehicle in each of the retracted and deployed positions, wherein the secondary latch release handle arm is extended forward to the deployed position by translational motion upon movement of the primary latch to the unlocked position. | 12-03-2015 |
20150367796 | ENERGY ABSORBING MEMBER FOR A BUMPER ASSEMBLY OF A VEHICLE - An energy absorbing member for a bumper assembly of a vehicle includes an open-celled foam. A magnetorheological fluid is disposed in the open-celled foam. A magnetic field source selectively controls a magnetic field in the open-celled foam. The open-celled foam includes cell walls and the magnetorheological fluid coats the cell walls and defines open cells unfilled by magnetorheological fluid. | 12-24-2015 |
20150375638 | AUTOMATIC PRESENTABLE SWIVELING SEAT - An automobile seat includes a cushion, a back coupled with the cushion, and a mounting unit. The mounting unit includes a mounting track and an actuator slidably coupled with the mounting track and coupled with the cushion. The actuator is extendable along an axis to move the cushion toward and away from the mounting track and is rotatable about the axis to rotate the cushion relative to the mounting track. | 12-31-2015 |
20160023637 | WINDOW WIPER SYSTEM FOR PROVIDING ENHANCED PERFORMANCE IN WINTER WEATHER CONDITIONS - A window wiper system is provided for enhanced performance in winter weather conditions. The wiper system includes a wiper assembly having a wiper base, a wiper arm pivotally connected to the wiper base and wiper blade carried on the wiper arm. An actuator carried on the wiper assembly selectively displaces the wiper arm between an operating position wherein the wiper blade engages and sweeps the vehicle window and a raised position wherein the wiper blade is lifted from the vehicle window. When the wiper blade is displaced from the raised position to the operating position it impacts the window with sufficient force to remove any accumulated ice from the wiper assembly without damaging the assembly or the window. | 01-28-2016 |
20160031401 | Roof Mounted Rear Seat Airbag Safety Cage - Described herein is a rear seat airbag deployment system, a rear seat airbag of the rear seat airbag deployment system, and a method of deploying the rear seat airbag. The rear seat airbag is configured in a substantially ‘U’ shape to encompass both the front and rear sides of rear seat occupants when the rear seat airbag is deployed. It follows that the rear seat airbag provides a safety cage that surrounds rear seat passengers upon deployment. Exemplary embodiments may further include an airbag deployment tool for gathering vehicle state information, analyzing the vehicle state information, determining whether to deploy one or more airbags, and controlling the deployment of the rear seat airbag. | 02-04-2016 |
20160046249 | ADAPTIVE ENERGY ABSORBER FOR A VEHICLE - An energy absorption system comprises a vehicle bumper, an energy absorption member attached to the vehicle bumper, and a plurality of ribs having respective first ends that are hingedly attached to the energy absorption member. The ribs extend between the energy absorption member and the bumper. The ribs may be actuated based on the speed information from the onboard vehicle communication network. | 02-18-2016 |
20160068127 | BUMPER MOUNTED DEPLOYABLE UPPER LEG CATCHER FOR PEDESTRIAN PROTECTION - A pedestrian protection apparatus for a motor vehicle is disclosed. The apparatus includes a catcher beam and a catcher beam support assembly including a catcher beam support to which the beam is attached. The support is movable between stowed and deployed positions. The apparatus includes a bumper energy absorber and a bumper beam. The assembly is positioned adjacent the absorber and either substantially within or adjacent to the bumper beam. The apparatus includes a mechanical, electromechanical or pneumatic actuator to allow the support to move to its deployed position. A pedestrian impact sensor sends a signal to a control unit in the event of an imminent pedestrian impact. The control unit then signals the assembly to allow the catcher beam to move to its deployed position by the use of the actuator. In the event of a false positive deployment, the actuator retracts the catcher beam to its stowed position. | 03-10-2016 |
20160082919 | HINGE FOR A VEHICLE HOOD - A hinge for a hood of a vehicle includes a first bracket; a member rotatably coupled to the first bracket, and a second bracket rotatably coupled to the member. An actuator includes a base connected to the member and a rod moveable relative to the base. The rod moves from a retracted position to an extended position in contact with the second bracket for rotating the second bracket relative to the member. | 03-24-2016 |
Patent application number | Description | Published |
20090192867 | DEVELOPING, IMPLEMENTING, TRANSFORMING AND GOVERNING A BUSINESS MODEL OF AN ENTERPRISE - The present disclosure relates to methods and systems for developing, implementing, transforming, and governing a business model of an enterprise. In some embodiments, a method of implementing and managing a business model of an enterprise includes defining a business model using a business model tool that is executed by a computer, wherein the business model is based on interrelated business strategy, business goal and business constraint data, and includes a business service, inputting into the computer a first set of data representing a benchmark performance value of the business service, and operating the enterprise in accordance with the business model. The enterprise is monitored to determine an actual performance value of the business service, and the actual performance value and the benchmark performance value are processed in the computer to affect a comparison therebetween. The business model is modified based on the comparison. | 07-30-2009 |
20120233328 | ACCURATELY PREDICTING CAPACITY REQUIREMENTS FOR INFORMATION TECHNOLOGY RESOURCES IN PHYSICAL, VIRTUAL AND HYBRID CLOUD ENVIRONMENTS - A method, system and computer program product for accurately predicting capacity requirements for Information Technology (IT) resources in physical, virtual, cloud and hybrid cloud environments. The business demand is translated into IT application demand, which is translated into IT architecture layer demand. Resource groups are created for each IT application, IT architecture layer and resource type combination. The utilization for each IT resource group within the IT architecture layers is computed using the created resource groups, IT application demand and IT architecture layer demand. Under or over-utilized IT resource groups may be identified using the computed utilization for each IT resource group. Upon identifying such IT resources, an optimal resource profile (e.g., number of servers) for each resource group is computed. In this manner, the utilization of IT resources can be more accurately predicted thereby allowing the IT resources to be used more effectively without over-utilizing or underutilizing these resources. | 09-13-2012 |
20130117157 | OPTIMALLY SOURCING SERVICES IN HYBRID CLOUD ENVIRONMENTS - A method, system and computer program product for selecting the optimal cloud service provider(s) to service a user's needs. A physical capacity of servers in a non-virtualized data center is converted into a cloud capacity to be used. A list of cloud service providers may be generated from a catalog of providers based on the cloud capacity to be used. Additional requirements and constraints received from the user are used to select an optimal cloud service provider(s) from the generated list of cloud service providers. | 05-09-2013 |
Patent application number | Description | Published |
20090185129 | BISTABLE FERROELECTRIC LIQUID CRYSTAL DEVICES - A liquid crystal electro-optic device. The liquid crystal electro-optic device comprises at least one liquid crystal cell comprising: a pair of substrates having a gap therebetween; a pair of electrodes, the pair of electrodes positioned on one of the substrates or one electrode positioned on each substrate; and a ferroelectric, oligosiloxane liquid crystal material disposed in the gap between the pair of substrates, the ferroelectric, oligosiloxane liquid crystal material exhibiting an I-♦ SmC* phase sequence wherein the liquid crystal electro-optic device is bistable in operation. The invention also involves a method for making a liquid crystal electro-optic device. | 07-23-2009 |
20100283925 | OLIGOSILOXANE MODIFIED LIQUID CRYSTAL FORMULATIONS AND DEVICES USING SAME - A liquid crystal formulation is described. The liquid crystal formulation comprises a first oligosiloxane-modified nano-phase segregating liquid crystalline material; and at least one additional material selected from a second oligosiloxane-modified nano-phase segregating liquid crystalline material, non-liquid crystalline oligosiloxane-modified materials, organic liquid crystalline materials, or non-liquid crystalline materials, wherein the liquid crystal formulation has an I→SmA*→SmC* phase transition, with a SmC* temperature range from about 15° C. to about 35° C., a tilt angle of about 22.5°±6° or about 45°±6°, a spontaneous polarization of less than about 50 nC/cm2., and a rotational viscosity of less than about 600 cP. Devices containing liquid crystal formulations are also described. The device has a stable bookshelf geometry, bistable switching, and isothermal electric field alignment, a response time of less than 500 μs when switched between two stable states, and an electric drive field of less than about 30 V/μm. | 11-11-2010 |
20100283927 | OLIGOSILOXANE MODIFIED LIQUID CRYSTAL FORMULATIONS AND DEVICES USING SAME - A liquid crystal formulation is described. The liquid crystal formulation comprises a first oligosiloxane-modified nano-phase segregating liquid crystalline material; and at least one additional material selected from a second oligosiloxane-modified nano-phase segregating liquid crystalline material, non-liquid crystalline oligosiloxane-modified materials, organic liquid crystalline materials, or organic non-liquid crystalline materials, wherein the liquid crystal formulation is nano-phase segregated in the SmC* phase, has an I→SmC* phase transition, with a SmC* temperature range from about 15° C. to about 35° C., has a tilt angle of about 22.5°±6° or about 45°±6°, and has a spontaneous polarization of less than about 50 nC/cm2, and a rotational viscosity of less than about 600 cP. Devices containing liquid crystal formulations are also described. The device has a stable bookshelf geometry, bistable switching, and isothermal electric field alignment, a response time of less than 500 μs when switched between two stable states, and an electric drive field of less than about 30 V/μm. | 11-11-2010 |
Patent application number | Description | Published |
20090074786 | FORMULATIONS FOR TREATING OCULAR DISEASES AND CONDITIONS - Diseases and conditions associated with tissues of the body, including but not limited to tissues in the eye, can be effectively treated, prevented, inhibited, onset delayed, or regression caused by administering therapeutic agents to those tissues. Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium of a subject; non-dispersed mass-forming liquid formulations which form a gel or gel-like substance in an aqueous medium; liquid formulations, comprising a therapeutic agent and a plurality of polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including but not limited to via intraocular or periocular administration, or placement proximate to a site of a disease or condition to be treated in a subject. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration, or wet age-related macular degeneration in a subject. The liquid formulations may comprise rapamycin or other therapeutic agents. | 03-19-2009 |
20100227879 | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS - Diseases and conditions associated with tissues of the body, including but not limited to tissues in the eye, can be effectively treated, prevented, inhibited, onset delayed, or regression caused by administering therapeutic agents to those tissues. Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium of a subject; non-dispersed mass-forming liquid formulations which form a gel or gel-like substance in an aqueous medium; liquid formulations, comprising a therapeutic agent and a plurality of polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including but not limited to via intraocular or periocular administration, or placement proximate to a site of a disease or condition to be treated in a subject. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration, or wet age-related macular degeneration in a subject. The liquid formulations may comprise rapamycin or other therapeutic agents. | 09-09-2010 |
20130197024 | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS - Diseases and conditions associated with tissues of the body, including but not limited to tissues in the eye, can be effectively treated, prevented, inhibited, onset delayed, or regression caused by administering therapeutic agents to those tissues. Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium of a subject; non-dispersed mass-forming liquid formulations which form a gel or gel-like substance in an aqueous medium; liquid formulations, comprising a therapeutic agent and a plurality of polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including but not limited to via intraocular or periocular administration, or placement proximate to a site of a disease or condition to be treated in a subject. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration, or wet age-related macular degeneration in a subject. The liquid formulations may comprise rapamycin or other therapeutic agents. | 08-01-2013 |
20140194461 | RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE - Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal neovascularization, wet AMD and dry AMD, and preventing transition of dry AMD to wet AMD, using the liquid rapamycin formulations described herein. | 07-10-2014 |
20150150794 | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS - Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium of a subject; liquid formulations comprising a therapeutic agent and a plurality of polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including but not limited to via intraocular or periocular administration. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration in a subject. | 06-04-2015 |